| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Supernus Pharmaceuticals Inc | |
|---|---|
| Ticker | SUPN |
| CIK # | 0001356576 |
| CUSIP | 868459108 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1550 E Gude Dr, Rockville, MD 20850 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Supernus Pharmaceuticals Inc | 2011-02-02 | 30.0 M | Exemption: 506 · Minimum: $2,000,000 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001356576] | 10-K | |
| [0001356576] | 10-Q | |
| [0001356576] | 3 | |
| [0001356576] | 4 | |
| [0001356576] | 5 | |
| [0001356576] | 8-K | |
| [0001356576] | SC 13D | |
| [0001356576] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-18 | Option exercise | 7,250 | $0.00 | |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-18 | Sell | 412 | $50.48 | 20,798 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-18 | Option exercise | 7,250 | $39.40 | 285,650 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-18 | Sell | 6,838 | $49.55 | 338,823 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-17 | Option exercise | 22,750 | $39.40 | 896,350 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-17 | Sell | 22,290 | $50.73 | 1,130,772 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-17 | Option exercise | 15,000 | $38.60 | 579,000 |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 22,750 | $0.00 | |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-17 | Option exercise | 12,250 | $36.75 | 450,188 |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 12,250 | $0.00 | |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 15,000 | $0.00 | |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-17 | Sell | 27,710 | $49.95 | 1,384,114 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-16 | Option exercise | 5,000 | $27.94 | 139,700 |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-16 | Option exercise | 22,750 | $36.75 | 836,062 |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 18,000 | $0.00 | |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 22,750 | $0.00 | |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-16 | Option exercise | 4,250 | $29.61 | 125,842 |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 5,000 | $0.00 | |
|
Bhatt Padmanabh P
Common Stock
|
2026-03-16 | Sell | 34,114 | $50.18 | 1,711,841 |
|
Bhatt Padmanabh P
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 4,250 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 329 | 56,937,244 |
| 2025-12-31 | 335 | 55,885,415 |
| 2025-09-30 | 311 | 56,671,173 |
| 2025-06-30 | 296 | 58,084,108 |
| 2025-03-31 | 295 | 56,591,335 |
| 2024-12-31 | 294 | 57,038,321 |
| 2024-09-30 | 273 | 57,483,709 |
| 2024-06-30 | 245 | 55,842,731 |
| 2024-03-31 | 252 | 53,702,673 |
| 2023-12-31 | 246 | 53,333,792 |
| 2023-09-30 | 238 | 51,837,682 |
| 2023-06-30 | 249 | 52,308,653 |